Eduardo A. Albornoz

1.6k total citations · 1 hit paper
18 papers, 992 citations indexed

About

Eduardo A. Albornoz is a scholar working on Molecular Biology, Neurology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Eduardo A. Albornoz has authored 18 papers receiving a total of 992 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Neurology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Eduardo A. Albornoz's work include Thyroid Disorders and Treatments (5 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Eduardo A. Albornoz is often cited by papers focused on Thyroid Disorders and Treatments (5 papers), Parkinson's Disease Mechanisms and Treatments (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Eduardo A. Albornoz collaborates with scholars based in Australia, Chile and United States. Eduardo A. Albornoz's co-authors include Trent M. Woodruff, Richard D. Gordon, Avril A. B. Robertson, Matthew A. Cooper, Kate Schroder, Monica R. Langley, Susanna Mantovani, Luke O'neill, Anumantha G. Kanthasamy and Dominic B. Rowe and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Brain.

In The Last Decade

Eduardo A. Albornoz

14 papers receiving 989 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice

2018 669 citations Richard D. Gordon, Eduardo A. Albornoz et al. Science Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eduardo A. Albornoz Australia	10	517	359	257	179	145	18	992
Susanna Mantovani Australia	13	606 1.2×	410 1.1×	349 1.4×	201 1.1×	268 1.8×	17	1.3k
Maria Swanberg Sweden	13	338 0.7×	451 1.3×	147 0.6×	179 1.0×	329 2.3×	28	1.1k
Meng-Liang Zhao United States	15	389 0.8×	540 1.5×	181 0.7×	261 1.5×	387 2.7×	17	1.4k
Nataša Kuštrimović Italy	16	197 0.4×	273 0.8×	273 1.1×	134 0.7×	124 0.9×	34	807
Carolina Prado Chile	19	237 0.5×	299 0.8×	143 0.6×	89 0.5×	354 2.4×	30	1.1k
Hyeon-Sook Suh United States	12	273 0.5×	260 0.7×	122 0.5×	132 0.7×	253 1.7×	12	856
Katherine E. Olson United States	19	209 0.4×	578 1.6×	372 1.4×	244 1.4×	165 1.1×	25	999
Bernadett Martinecz Hungary	8	308 0.6×	574 1.6×	99 0.4×	134 0.7×	234 1.6×	9	913
Hannah Ennerfelt United States	10	255 0.5×	293 0.8×	157 0.6×	161 0.9×	178 1.2×	17	808
David J. Braun United States	15	205 0.4×	223 0.6×	136 0.5×	163 0.9×	139 1.0×	22	837

Countries citing papers authored by Eduardo A. Albornoz

Since Specialization

Citations

This map shows the geographic impact of Eduardo A. Albornoz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo A. Albornoz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo A. Albornoz more than expected).

Fields of papers citing papers by Eduardo A. Albornoz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo A. Albornoz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo A. Albornoz. The network helps show where Eduardo A. Albornoz may publish in the future.

Co-authorship network of co-authors of Eduardo A. Albornoz

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo A. Albornoz. A scholar is included among the top collaborators of Eduardo A. Albornoz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo A. Albornoz. Eduardo A. Albornoz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Albornoz, Eduardo A., Richard D. Gordon, Ibrahim Javed, et al.. (2025). Microglial Complement C5aR1 signalling drives inflammasome mediated neuropathology in Parkinson’s disease. Immunobiology. 230(4). 152955–152955.

Albornoz, Eduardo A., Karine Mardon, Rajiv Bhalla, et al.. (2025). PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson’s disease models. Brain.

Parker, Sandra K., Jonathan J. Lee, Xaria X. Li, et al.. (2025). Live-cell single-molecule imaging of a new fluorescent C5a receptor antagonist reveals the heterogeneous spatiotemporal dynamics of C5aR1 at the plasma membrane. Immunobiology. 230(4). 152969–152969.

Cao, Yang, Giovanni Pietrogrande, Richard J. Clark, et al.. (2025). Motor neuron disease C9orf72 dipeptides mediate neurotoxicity in human brain organoids through activation of C5aR1. Immunobiology. 230(4). 153008–153008.

Amarilla, Alberto A., John D. Lee, Eduardo A. Albornoz, et al.. (2022). SARS‐CoV ‐2 triggers complement activation through interactions with heparan sulfate. Clinical & Translational Immunology. 11(8). e1413–e1413. 13 indexed citations

Isaacs, Ariel, Alberto A. Amarilla, Julio Aguado, et al.. (2022). Nucleocapsid Specific Diagnostics for the Detection of Divergent SARS-CoV-2 Variants. Frontiers in Immunology. 13. 926262–926262. 10 indexed citations

Lee, John D., Eduardo A. Albornoz, Luke McAlary, et al.. (2019). The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins. Glia. 68(2). 407–421. 154 indexed citations

Albornoz, Eduardo A., María Cecilia Opazo, Felipe Simón, et al.. (2018). Gestational Hypothyroxinemia Affects Its Offspring With a Reduced Suppressive Capacity Impairing the Outcome of the Experimental Autoimmune Encephalomyelitis. Frontiers in Immunology. 9. 1257–1257. 10 indexed citations

Albornoz, Eduardo A., Trent M. Woodruff, & Richard D. Gordon. (2018). Inflammasomes in CNS Diseases. PubMed. 108. 41–60. 33 indexed citations

10.

Giacomin, Paul, Ann-Katrin Kraeuter, Eduardo A. Albornoz, et al.. (2018). Chronic Helminth Infection Perturbs the Gut-Brain Axis, Promotes Neuropathology, and Alters Behavior. The Journal of Infectious Diseases. 218(9). 1511–1516. 11 indexed citations

11.

Gordon, Richard D., Eduardo A. Albornoz, Monica R. Langley, et al.. (2018). Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice. Science Translational Medicine. 10(465). 669 indexed citations breakdown →

12.

Albornoz, Eduardo A., et al.. (2017). The Ketone Body β-Hydroxybutyrate Does Not Inhibit Synuclein Mediated Inflammasome Activation in Microglia. Journal of Neuroimmune Pharmacology. 12(4). 568–574. 31 indexed citations

13.

Opazo, María Cecilia, Pablo A. González, Eduardo A. Albornoz, et al.. (2017). Gestational Hypothyroxinemia Imprints a Switch in the Capacity of Astrocytes and Microglial Cells of the Offspring to React in Inflammation. Molecular Neurobiology. 55(5). 4373–4387. 6 indexed citations

14.

Opazo, María Cecilia, Evelyn L. Jara, Eduardo A. Albornoz, et al.. (2017). Gestational hypothyroxinemia increases the immune response of the progeny that suffers experimental autoimmune encephalomyelitis.. The Journal of Immunology. 198(Supplement_1). 207.8–207.8. 1 indexed citations

15.

Gordon, Richard D., et al.. (2016). Complement C5a activates microglial NLRP3 inflammasomes and drives neurodegeneration in Parkinson's disease through C5aR1. Immunobiology. 221(10). 1190–1190. 3 indexed citations

16.

Albornoz, Eduardo A., María Cecilia Opazo, Álvaro Becerra, et al.. (2015). Excess Iodide Induces an Acute Inhibition of the Sodium/Iodide Symporter in Thyroid Male Rat Cells by Increasing Reactive Oxygen Species. Endocrinology. 156(4). 1540–1551. 31 indexed citations

17.

Albornoz, Eduardo A., Leandro J. Carreño, Claudia Cortés, et al.. (2013). Gestational Hypothyroidism Increases the Severity of Experimental Autoimmune Encephalomyelitis in Adult Offspring. Thyroid. 23(12). 1627–1637. 19 indexed citations

18.

Uribe, Rodrigo, et al.. (2007). Las audiencias de la franja presidencial chilena. SHILAP Revista de lepidopterología. 12–19. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact